Senseonics Holdings Inc SENS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $10.17
- Day Range
- $9.90–10.19
- 52-Week Range
- $4.79–11.58
- Bid/Ask
- $9.90 / $10.14
- Shares Outstanding
- 52.87M
- Market Cap
- $526.63M
- Volume/Avg
- 606,436 / 685,177
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 9.97
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 130
- Website
- https://www.senseonics.com
Valuation
|
Metric
|
SENS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 5.84 |
Price/Sales | 9.97 |
Price/Cash Flow | — |
Price/Earnings
SENS
Financial Strength
|
Metric
|
SENS
|
|---|---|
Quick Ratio | 6.22 |
Current Ratio | 6.74 |
Interest Coverage | −21.00 |
Quick Ratio
SENS
Profitability
|
Metric
|
SENS
|
|---|---|
Return on Assets (Normalized) | −70.48% |
Return on Equity (Normalized) | −136.83% |
Return on Invested Capital (Normalized) | −82.82% |
Return on Assets
SENS
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|>^C%kFR | LOCK|@yl< | $167B | |||
| Medtronic PLC
MDT
| LOCK|<Z$qG$# | LOCK|Brvh | $111B | |||
| Stryker Corp
SYK
| LOCK|RnYG?LC | LOCK|$Bf | $105B | |||
| Boston Scientific Corp
BSX
| LOCK|<<k?by | LOCK|pj^mD | $63B | |||
| Edwards Lifesciences Corp
EW
| LOCK|SmRy@&Dy | LOCK|S<$l | $49B | |||
| DexCom Inc
DXCM
| LOCK|Vm&<v%QH | LOCK|@^Myb | $33B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|#d^D?Z | LOCK|vw< | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|T^ | LOCK|W% | $23B | |||
| Steris PLC
STE
| LOCK|>#P!b^y | LOCK|vcNF | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|c@!n%<l | LOCK|<X@ | $17B |
United States